Baoyu Li
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
[Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.
Journal: Experimental and therapeutic medicine
Published: August 21, 2023
[Retracted] KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
[Retracted] KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Journal: Experimental and therapeutic medicine
Published: July 17, 2023
Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
Journal: Journal of clinical laboratory analysis
Published: September 01, 2020
Actin-binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.
Journal: Experimental and therapeutic medicine
Published: June 26, 2020
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Journal: Experimental and therapeutic medicine
Published: March 07, 2020
KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8.
Journal: Journal of cellular physiology
Published: May 30, 2019
A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: May 26, 2019
Down-regulation of LINC00341 predicts a poor prognosis and acts as a tumor suppressor in gastric cancer.
Journal: International journal of clinical and experimental pathology
Published: May 13, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026